Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$836M |
| 2 |
Microsoft
MSFT
|
+$748M |
| 3 |
Cigna
CI
|
+$560M |
| 4 |
3M
MMM
|
+$558M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$568M |
| 2 |
Zoom
ZM
|
+$557M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$516M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$479M |
| 5 |
Unity
U
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.71% |
| 2 | Healthcare | 11.34% |
| 3 | Financials | 9.38% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Communication Services | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Protagonist Therapeutics
PTGX
$9.8B
| $18.8M | ﹤0.01% |
2,227,575
+451,123
| +25% | +$4.27M |
|
|
VIVO
2252
DELISTED
Meridian Bioscience Inc
VIVO
| $18.8M | ﹤0.01% |
595,004
+194,099
| +48% | +$6.29M |
|
2253
Liberty Global Class C
LBTYK
$3.46B
| $18.8M | ﹤0.01% |
1,136,424
+160,161
| +16% | +$3.4M |
|
|
AXNX
2254
DELISTED
Axonics, Inc. Common Stock
AXNX
| $18.7M | ﹤0.01% |
265,736
+26,761
| +11% | +$1.85M |
|
2255
KB Home
KBH
$3.42B
| $18.7M | ﹤0.01% |
722,128
-128,433
| -15% | -$3.86M |
|
2256
PJT Partners
PJT
$4.36B
| $18.7M | ﹤0.01% |
279,511
+191,296
| +217% | +$13.4M |
|
|
BLDP
2257
Ballard Power Systems
BLDP
$790M
| $18.7M | ﹤0.01% |
3,049,435
-372,331
| -11% | -$2.78M |
|
2258
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.18B
| $18.7M | ﹤0.01% |
857,717
+562
| +0.1% | +$13.9K |
|
2259
Axos Financial
AX
$5.72B
| $18.6M | ﹤0.01% |
544,448
-56,126
| -9% | -$2.27M |
|
2260
Post Holdings
POST
$3.65B
| $18.6M | ﹤0.01% |
227,099
+16,110
| +8% | +$1.39M |
|
2261
TTM Technologies
TTMI
$14.6B
| $18.6M | ﹤0.01% |
1,410,565
-3,492
| -0.2% | -$50.3K |
|
|
RAPT
2262
DELISTED
RAPT Therapeutics
RAPT
| $18.6M | ﹤0.01% |
96,534
-33,910
| -26% | -$6.41M |
|
2263
State Street SPDR US Large Cap Low Volatility Index ETF
LGLV
$1.23B
| $18.6M | ﹤0.01% |
150,563
+14,274
| +10% | +$1.93M |
|
2264
Yelp
YELP
$1.28B
| $18.6M | ﹤0.01% |
547,858
+15,456
| +3% | +$511K |
|
2265
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$5.12B
| $18.5M | ﹤0.01% |
276,020
-81,310
| -23% | -$6.12M |
|
2266
iShares MSCI Taiwan ETF
EWT
$11.6B
| $18.5M | ﹤0.01% |
429,833
-301,346
| -41% | -$14.9M |
|
2267
CareTrust REIT
CTRE
$9.18B
| $18.5M | ﹤0.01% |
1,022,899
+128,116
| +14% | +$2.61M |
|
2268
ALPS Clean Energy ETF
ACES
$124M
| $18.5M | ﹤0.01% |
333,362
+139,383
| +72% | +$8.26M |
|
2269
uniQure
QURE
$3.26B
| $18.5M | ﹤0.01% |
985,764
-341,409
| -26% | -$7.18M |
|
|
NARI
2270
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $18.5M | ﹤0.01% |
254,252
-13,365
| -5% | -$995K |
|
|
KMF
2271
DELISTED
Kayne Anderson NextGen Energy & Infrastructure, Inc.
KMF
| $18.4M | ﹤0.01% |
2,608,791
-30,264
| -1% | -$246K |
|
|
IAA
2272
DELISTED
IAA, Inc. Common Stock
IAA
| $18.4M | ﹤0.01% |
578,834
-140,225
| -20% | -$4.98M |
|
|
RVNC
2273
DELISTED
Revance Therapeutics, Inc.
RVNC
| $18.4M | ﹤0.01% |
682,705
+179,621
| +36% | +$3.64M |
|
2274
State Street SPDR Portfolio Long Term Corporate Bond ETF
SPLB
$1.19B
| $18.4M | ﹤0.01% |
846,763
+202,328
| +31% | +$4.87M |
|
2275
Lemonade
LMND
$4.1B
| $18.4M | ﹤0.01% |
868,718
-377,380
| -30% | -$8.58M |
|
Similar funds
Morgan Stanley's Q3 2022 Portfolio in Review
As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
- Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
- Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
- Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
- Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
- Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.